Grant: Discovery Grants Program - Individual
McGill University
$29,000.00
Novel pathways in T lymphocyte differentiation and function
FY 2015-16
Summary
The ability to generate high-affinity antibodies to diverse infectious agents (i.e. humoral immunity) is a fundamental property of the vertebrate immune system and ensures host survival. The humoral immune response requires highly coordinated interactions between B lymphocytes (which possess antibody-producing potential) and ""helper"" T cells. These interactions are mediated by a subset of helper T cells termed T follicular helper (Tfh) cells that provide direct help to B cells through provision of membrane-bound co-stimulatory molecules and secretion of polarizing cytokines. We have previously shown that Tfh cells provide critical sources of interleukin (IL)-4 and IL-21 required for the generation of humoral immune responses in the context of immunization (King et al, Nature Immunology, 2012) and parasitic helminth infection (King and Mohrs, Journal of Experimental Medicine, 2009). This proposal builds on these findings to identify previously undescribed molecules and signaling pathways that specifically control T cell differentiation and function.
<span style=""line-height: 1.5em;"">To discover molecules uniquely expressed by Tfh cells, we performed preliminary experiments using microarray technology comparing this subset to other CD4+ T cell subsets isolated from the inflamed mesenteric lymph nodes of mice infected with an intestinal helminth. Our results indicate that Tfh cells express high levels of CD109 compared to other CD4+ T cells. CD109 is a glycophosphatidylinositol-anchored protein with unknown function in the immune system. Functional studies using keratinocytes have demonstrated that CD109 acts as a negative regulator of transforming growth factor (TGF)-b1 signaling, a cytokine that dramatically influences T effector cell differentiation. Preliminary results from my laboratory indicate that key TGF-b1 target genes such as SMAD7 are downregulated in Tfh cells, findings consistent with the idea that CD109 is also negatively regulating this signaling pathway in T cells. In addition, CD109 has been been shown to regulate STAT3, a transcription factor that promotes Tfh cell differentiation as well as other T effector subsets. Thus, an in-depth analysis of CD109 in T cell biology and its potential relationship to TGF-b1 and STAT3-dependent signaling in lymphocytes is warranted. In this application, we propose a research program to elucidate the function of CD109 in T cell activation and its specificity in controlling T cell differentiation and function by pursuing 3 specific objectives:
<span style=""line-height: 1.5em;"">
1. Identify the requirements for CD109 expression by CD4+ T cells.
2. Determine how CD109 impacts CD4+ T cell activation and differentiation.
3. Identify CD109 binding partners in activated CD4+ T cells.
Understanding the function of CD109 in T cell differentiation and/or function will provide new insight into the molecular mechanisms controlling this important immune cell population.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2015-05491
Name nom
King, Irah
Department département
Microbiology and Immunology - Microbiology and Immunology
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5105
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell differentiation
Research subject fr
Différenciation cellulaire
Partie
1
Nb partie
5
Application title
Novel pathways in T lymphocyte differentiation and function
Keyword
NSERC
Application summary
<p>The ability to generate high-affinity antibodies to diverse infectious agents (i.e. humoral immunity) is a fundamental property of the vertebrate immune system and ensures host survival. The humoral immune response requires highly coordinated interactions between B lymphocytes (which possess antibody-producing potential) and ""helper"" T cells. These interactions are mediated by a subset of helper T cells termed T follicular helper (Tfh) cells that provide direct help to B cells through provision of membrane-bound co-stimulatory molecules and secretion of polarizing cytokines. We have previously shown that Tfh cells provide critical sources of interleukin (IL)-4 and IL-21 required for the generation of humoral immune responses in the context of immunization (King et al, Nature Immunology, 2012) and parasitic helminth infection (King and Mohrs, Journal of Experimental Medicine, 2009). This proposal builds on these findings to identify previously undescribed molecules and signaling pathways that specifically control T cell differentiation and function.</p>
<p><span style=""line-height: 1.5em;"">To discover molecules uniquely expressed by Tfh cells, we performed preliminary experiments using microarray technology comparing this subset to other CD4+ T cell subsets isolated from the inflamed mesenteric lymph nodes of mice infected with an intestinal helminth. Our results indicate that Tfh cells express high levels of CD109 compared to other CD4+ T cells. CD109 is a glycophosphatidylinositol-anchored protein with unknown function in the immune system. Functional studies using keratinocytes have demonstrated that CD109 acts as a negative regulator of transforming growth factor (TGF)-b1 signaling, a cytokine that dramatically influences T effector cell differentiation. Preliminary results from my laboratory indicate that key TGF-b1 target genes such as SMAD7 are downregulated in Tfh cells, findings consistent with the idea that CD109 is also negatively regulating this signaling pathway in T cells. In addition, CD109 has been been shown to regulate STAT3, a transcription factor that promotes Tfh cell differentiation as well as other T effector subsets. Thus, an in-depth analysis of CD109 in T cell biology and its potential relationship to TGF-b1 and STAT3-dependent signaling in lymphocytes is warranted. In this application, we propose a research program to elucidate the function of CD109 in T cell activation and its specificity in controlling T cell differentiation and function by pursuing 3 specific objectives:</span></p>
<p><span style=""line-height: 1.5em;""></span><br />
1. Identify the requirements for CD109 expression by CD4+ T cells.<br />
2. Determine how CD109 impacts CD4+ T cell activation and differentiation. <br />
3. Identify CD109 binding partners in activated CD4+ T cells. <br />
<br />
Understanding the function of CD109 in T cell differentiation and/or function will provide new insight into the molecular mechanisms controlling this important immune cell population.</p>